These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 29876924)
1. Cyclophilin B induces chemoresistance by degrading wild-type p53 via interaction with MDM2 in colorectal cancer. Choi TG; Nguyen MN; Kim J; Jo YH; Jang M; Nguyen NNY; Yun HR; Choe W; Kang I; Ha J; Tang DG; Kim SS J Pathol; 2018 Sep; 246(1):115-126. PubMed ID: 29876924 [TBL] [Abstract][Full Text] [Related]
2. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53. Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854 [TBL] [Abstract][Full Text] [Related]
3. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity. Di Y; Jing X; Hu K; Wen X; Ye L; Zhang X; Qin J; Ye J; Lin R; Wang Z; He W Drug Resist Updat; 2023 Jan; 66():100909. PubMed ID: 36525936 [TBL] [Abstract][Full Text] [Related]
4. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52. Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837 [TBL] [Abstract][Full Text] [Related]
5. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop. Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750 [TBL] [Abstract][Full Text] [Related]
6. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer. Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of DJ-1 enhances colorectal cancer cell proliferation through the cyclin-D1/MDM2-p53 signaling pathway. Zhu X; Luo C; Lin K; Bu F; Ye F; Huang C; Luo H; Huang J; Zhu Z Biosci Trends; 2020 May; 14(2):83-95. PubMed ID: 32132307 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA PiHL regulates p53 protein stability through GRWD1/RPL11/MDM2 axis in colorectal cancer. Deng X; Li S; Kong F; Ruan H; Xu X; Zhang X; Wu Z; Zhang L; Xu Y; Yuan H; Peng H; Yang D; Guan M Theranostics; 2020; 10(1):265-280. PubMed ID: 31903119 [TBL] [Abstract][Full Text] [Related]
9. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation. Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406 [TBL] [Abstract][Full Text] [Related]
10. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin. Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059 [TBL] [Abstract][Full Text] [Related]
11. GRIM-19 inhibits proliferation and induces apoptosis in a p53-dependent manner in colorectal cancer cells through the SIRT7/PCAF/MDM2 axis. Wang D; Wei X; Chen X; Wang Q; Zhang J; Kalvakolanu DV; Guo B; Zhang L Exp Cell Res; 2021 Oct; 407(1):112799. PubMed ID: 34461110 [TBL] [Abstract][Full Text] [Related]
12. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines. Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657 [TBL] [Abstract][Full Text] [Related]
13. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol inhibits MDM2 and induces apoptosis in breast cancer cells through a p53-independent pathway. Xu J; Han M; Shen J; Guan Q; Bai Z; Lang B; Zhang H; Li Z; Zuo D; Zhang W; Wu Y Cancer Lett; 2016 Dec; 383(1):9-17. PubMed ID: 27693458 [TBL] [Abstract][Full Text] [Related]
14. Novel exosomal miR-46146 transfer oxaliplatin chemoresistance in colorectal cancer. Xu Y; Zhu M Clin Transl Oncol; 2020 Jul; 22(7):1105-1116. PubMed ID: 31728833 [TBL] [Abstract][Full Text] [Related]
15. FL118 induces p53-dependent senescence in colorectal cancer cells by promoting degradation of MdmX. Ling X; Xu C; Fan C; Zhong K; Li F; Wang X Cancer Res; 2014 Dec; 74(24):7487-97. PubMed ID: 25512388 [TBL] [Abstract][Full Text] [Related]
16. Ribosomal L1 domain-containing protein 1 coordinates with HDM2 to negatively regulate p53 in human colorectal Cancer cells. Ding L; Zhang Z; Zhao C; Chen L; Chen Z; Zhang J; Liu Y; Nie Y; He Y; Liao K; Zhang X J Exp Clin Cancer Res; 2021 Aug; 40(1):245. PubMed ID: 34362424 [TBL] [Abstract][Full Text] [Related]
17. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis. Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028 [TBL] [Abstract][Full Text] [Related]
18. Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation. Wu AY; Gu LY; Cang W; Cheng MX; Wang WJ; Di W; Huang L; Qiu LH J Exp Clin Cancer Res; 2019 Apr; 38(1):176. PubMed ID: 31023317 [TBL] [Abstract][Full Text] [Related]
19. FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2. Liu T; Xiong J; Yi S; Zhang H; Zhou S; Gu L; Zhou M Oncogene; 2017 Mar; 36(12):1678-1686. PubMed ID: 27617579 [TBL] [Abstract][Full Text] [Related]
20. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145. Gao R; Fang C; Xu J; Tan H; Li P; Ma L Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]